SynThera is developing proprietary IP-driven bioactive glass products that aid bone and tooth repair with improved healing outcomes at highly affordable prices.
*Products: Bioactive bone graft substitutes for dentistry and orthopaedics *Brands: SynOst (generic) and PoroSyn (proprietary) *Current status: Prototypes ready, testing complete (SynOst) or ongoing (PoroSyn) *IP Status: Provisional patent filed for PoroSyn, Freedom to Operate established for SynOst *Price points: Rs. 3600+ per cc *Market entry: 2018-19 *Market size: USD 2.5 billion+ (global), INR 500 cr+ (India)
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free